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   Retraction Notice to 
ARTIFICIAL INTELLIGENCE IN 
PHARMACEUTICAL PRODUCT 
FORMULATION: NEURAL COMPUTING 
[Chem. Ind. Chem. Eng. Q. 15(4) (2009) 227-236] 
This article has been retracted at the request of the authors. 
 
The retraction has been made because the authors admitted that they took the 
text and drawings from the review article written by R. Rowe and E. Colbourn, 
Future Medicinal Chemistry 1(4) (2009) 713-726, without their permission and 
even did not include this article in the list of references. 
 
One of the conditions of submission of a paper for publication are that authors 
confirm that their work is entirely originally written, someone else’s data and/or 
text are appropriately cited or quoted and permission has been obtained for 
use of copyrighted material from other sources. Therefore, the retracted article 
represents a severe improperly usage of the scientific publishing system. 
Apologies are offered to readers of the Chem. Ind. Chem. Eng. Q. that this 
abuse was not detected during the submission process. 
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